Stephen Rego, PhD, is a Senior Clinical Protocol Development Associate for UNC Lineberger Comprehensive Cancer Center at the University of North Carolina Chapel Hill. Stephen assists investigators in developing various documents associated with clinical trial development and maintenance including letters of intent, initial clinical trial protocols, protocol amendments, and administrative letters.
He also acts as a liaison between pharmaceutical companies and the principal investigators during trial development and during the life of the study. Additionally, Stephen drafts patient-facing materials including informed consent forms and performs quality assurance activities for both consent documents and clinical protocols.
Previously, Stephen served as a Scientific Consultant/Team Lead for Eva Garland Consulting, an Industry Trainer for the NCBioNetwork through Wake Technical Community College, and an Instructor at Forsyth Technical Community College. Stephen completed two postdoctoral research fellowships at Wake Forest Baptist Medical Center in the Wake Forest Institute of Regenerative Medicine and Biochemistry Department. Stephen received his PhD in Cellular and Molecular Biology from the University of North Carolina at Charlotte and BS in Biology from East Carolina University.
